Telegraft Hub Home

In this edition of "From the President's Desk" , ISCT President Miguel Forte writes of the development and promise of cell and gene therapy product approvals throughout 2024. Through a quick review of the year's advancements, Dr. Forte traces the fascinating journey of Mesoblast's Ryoncil from its early clinical development to its recent hard-won FDA approval. 

Read More

presdesk.png

Telegraft Senior Editor Russell Cruz reflects on the state of biomedical research funding in the U.S., considering potential massive shifts in the context of years of increasing discontent with the U.S. biomedical research enterprise. Dr. Cruz examines how the research community must identify ways to streamline funding and its use, foster public engagement, and rebuild public trust by producing tangible societal benefits beyond publishing papers and securing grants. 

Read More

The ISCT Institute of Training & Development is thrilled to announce the launch of the 2025 ISCT Cell Therapy Leadership Training Program—a premier initiative designed to develop the next generation of leaders in Cell and Gene Therapy (CGT).

Read more

From_the_Presidents_Desk.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png
Scientific_Spotlight_2.png

ISCT Calendar

Upcoming Events

View_Calendar.png

ISCT 2024 Annual Meeting